Business Description
Koninklijke DSM NV
ISIN : NL0000009827
Share Class Description:
KDSKF: Registered SharesDescription
Koninklijke DSM NV is a purpose-led company in Health, Nutrition, and Bioscience, applying science to improve the health of people, animals, and the planet. The company delivers innovative business solutions for human and animal nutrition, personal care and aroma, medical devices, green products and applications, new mobility, and connectivity. The company's segment includes Animal Nutrition & Health (ANH), Health, Nutrition & Care (HNC), and Food & Beverage (F&B), where the majority of its revenue is generated from Animal Nutrition & Health (ANH).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.73 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | 4.44 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.71 | |||||
| Beneish M-Score | -1.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6 | |||||
| 3-Year EBITDA Growth Rate | -42.5 | |||||
| 3-Year FCF Growth Rate | -70.1 | |||||
| 3-Year Book Growth Rate | 1.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.86 | |||||
| 9-Day RSI | 8.27 | |||||
| 14-Day RSI | 10.05 | |||||
| 6-1 Month Momentum % | -76.75 | |||||
| 12-1 Month Momentum % | -15.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.94 | |||||
| Quick Ratio | 1.25 | |||||
| Cash Ratio | 0.68 | |||||
| Days Inventory | 151.44 | |||||
| Days Sales Outstanding | 67.24 | |||||
| Days Payable | 90.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 13.07 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.06 | |||||
| Operating Margin % | 7.67 | |||||
| Net Margin % | 20.27 | |||||
| FCF Margin % | 3.75 | |||||
| ROE % | 17.15 | |||||
| ROA % | 10.11 | |||||
| ROIC % | 4.2 | |||||
| ROC (Joel Greenblatt) % | 12.93 | |||||
| ROCE % | 5.25 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2.47 | |||||
| Forward PE Ratio | 4.08 | |||||
| PE Ratio without NRI | 9.11 | |||||
| Shiller PE Ratio | 3.31 | |||||
| Price-to-Owner-Earnings | 1.65 | |||||
| PS Ratio | 0.5 | |||||
| PB Ratio | 0.46 | |||||
| Price-to-Tangible-Book | 1.12 | |||||
| Price-to-Free-Cash-Flow | 13.16 | |||||
| Price-to-Operating-Cash-Flow | 4.34 | |||||
| EV-to-EBIT | 6.93 | |||||
| EV-to-Forward-EBIT | 2.05 | |||||
| EV-to-EBITDA | 6.93 | |||||
| EV-to-Forward-EBITDA | 1.3 | |||||
| EV-to-Revenue | 0.6 | |||||
| EV-to-Forward-Revenue | 0.27 | |||||
| EV-to-FCF | 15.97 | |||||
| Price-to-Projected-FCF | 0.32 | |||||
| Price-to-Median-PS-Value | 0.3 | |||||
| Price-to-Graham-Number | 1.09 | |||||
| Earnings Yield (Greenblatt) % | 14.43 | |||||
| FCF Yield % | 7.56 | |||||
| Forward Rate of Return (Yacktman) % | -8.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KDSKF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Koninklijke DSM NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8,878.496 | ||
| EPS (TTM) ($) | 10.263 | ||
| Beta | 0 | ||
| Volatility % | 307.62 | ||
| 14-Day RSI | 10.05 | ||
| 14-Day ATR ($) | 0.04844 | ||
| 20-Day SMA ($) | 25.3 | ||
| 12-1 Month Momentum % | -15.67 | ||
| 52-Week Range ($) | 12.5 - 108.8 | ||
| Shares Outstanding (Mil) | 174.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Koninklijke DSM NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Koninklijke DSM NV Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Koninklijke DSM NV Frequently Asked Questions
What is Koninklijke DSM NV(KDSKF)'s stock price today?
The current price of KDSKF is $25.30. The 52 week high of KDSKF is $108.80 and 52 week low is $12.50.
When is next earnings date of Koninklijke DSM NV(KDSKF)?
The next earnings date of Koninklijke DSM NV(KDSKF) is 2025-02-16 Est..
Does Koninklijke DSM NV(KDSKF) pay dividends? If so, how much?
Koninklijke DSM NV(KDSKF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers